Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Ugro Capital Limited has informed the Exchange regarding allotment of 250 securities pursuant to Non Convertible Securities at its meeting held on January 19, 2022
Orchid Pharma Limited has informed the Exchange regarding Disclosure under Regulation 29 (1) of SEBI (SAST) Regulation 2011.
Ramkrishna Forgings Limited has informed the Exchange regarding Update on Postal Ballot.
Infosys Limited has informed the Exchange regarding a press release dated January 20, 2022, titled Infosys Positioned as a Leader in IDC MarketScape: Worldwide B2B Commerce Services for Industrial Manufacturing 2021 Vendor Assessment.
Tata Motors Limited has informed the Exchange about Loss of Share Certificates
Tata Steel Long Products Limited has informed the Exchange regarding Announcement under Regulation 30 (LODR)-Press Release.
INEOS Styrolution India Limited has informed the Exchange about Loss of Share Certificates
TCPL Packaging Limited has informed the Exchange about Loss of Share Certificates
Asian Paints Limited has informed the Exchange regarding Board meeting held on January 20, 2022.

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.